A 60-yr-old woman and her brother, products of a consanquinous mating, were chylomicronemic. The chylomicronemia in both subjects was found to be due to the absence of functional apoCI. A mutant form, designated apoClIst. Michael (apo-CIIS), was identified by two-dimensional electrophoresis and Western blot using anti-apoCII antiserum. The isoelectric point of apoCIls was similar to that of normal apoClI, but its apparent molecular weight was 3,000 greater. Tryptic peptides of apoCIIs were identified that had retention times in reversephase high pressure liquid chromatography and amino acid compositions indistinguishable from that of residues 1 to 48 and 51 to 55 of normal apoCI. The complete sequence of apoClIs was deduced fromn a combination of the sequence analysis of tryptic peptides corresponding to residues 56 through 96 and the known sequence of the apoCII gene. ApoCIIs differed from apoCHI at residue 70 where Gln70 was replaced by Pro70 and the sequence terminated with Pro6. This is consistent with a base insertion in the codon for Asp69 or Gln70 in the apoCII gene and a subsequent translation reading frame shift. Both patients were homozygous for apoE4. This and the absence of normal apoCII is consistent with homozygozity at the apoE-CII gene locus on chromosome 19. Both siblings and several relatives had premature ischemic vascular disease, in contrast with its apparent absence in other apoCII-deficient families.
Introduction apoCIl is known to be an activator of lipoprotein lipase (LPL),' the primary enzyme involved in the lipolysis ofplasma triglyceride (TG) of chylomicrons and VLDL (1, 2) . The discovery in this laboratory of a subject with fasting chylomicronemia caused by a deficiency of apoCII (3) established the physiological importance of the apolipoprotein as an activator of LPL. The deficiency was identified as an autosomal recessive trait (4) . The phenotypic deficiency of functional apoCII has been reported in eight other families (5) (6) (7) (8) (9) (10) . apoCIIT0~nt,; HL, hepatic lipase; LPL, lipoprotein lipase; PY, pyridylethylated; Sf, Svedberg units of flotation; TG, triglyceride.
We previously reported that the 14 homozygotes and 23 obligate heterozygotes from the apoCII-deficient family described by this laboratory are characterized by the presence of a mutant, nonfunctional apoCII, apoCIITOrmftO (apoCIIT) (11) .
ApoCIIT was shown to differ from normal apoCII in its amino acid sequence starting at residue 69 (12) . Two other different apoCII-deficient families have been reported to have trace amounts of mutant forms of apoCII, apoCIIBethesd.a and apoCIIpad,, in their plasma (13) . The precise structure of these mutants has not been described; however, their pI and migration in two-dimensional electrophoresis distinguish them from normal apoCII and apoCIIT. A variant of apoCII, apo-CII2(Gln55), is present in 12% of individuals of African descent (14) and has been reported to activate bovine milk lipoprotein lipase in vitro as efficiently as normal apoCII (15) .
We now report the discovery of a new family with apoCII deficiency characterized by the presence of a mutant form of apoCII that we have designated apoCIIst. Michael (apoClIs). It differs from normal apoCII at residue 70, where Gln70 is replaced by Pro70 and the sequence terminates with Pro96. This is consistent with a base insertion in the apoCII gene and a subsequent translation reading frame shift. These subjects present with fasting hyperchylomicronemia and significant ischemic vascular disease, a finding that contrasts with the absence of premature ischemic vascular disease in other homozygotes for apoCII deficiency (16) .
Methods
Clinical data Proband. The proband, a 58-yr-old white Anglo-Saxon female, was referred to the Lipid Clinic at St. Michael's Hospital on December 4, 1984 with a ten-year history of lipemia. While on oral contraceptives she had two attacks of epigastric pain with markedly elevated serum amylase activity that was diagnosed as pancreatitis. She had six fullterm uncomplicated, normal deliveries, including a pair of twins. However, tonsillectomy, tooth extractions, and hemorrhoidectomy were complicated by several days of bleeding. The menopause occurred at age 50. Her average adult weight was 68 kg. She did not use tobacco or alcohol. She took 1 g clofibrate twice daily until five weeks ago.
Her parents were first cousins once removed. Her father had three heart attacks in the sixth decade and died at 70 yr of age; the mother had non-insulin-dependent diabetes mellitus and died at 84; a maternal uncle died of a heart attack at age 60. The proband had seven siblings; one died of "internal bleeding" at 28 yr, one of a heart attack at 56, one of hypertension and a heart attack at 68, one was alive and well at 57, one had a heart attack at 53 and was alive at 60, one brother described below was alive at 61 with lipemia, recurrent acute pancreatitis, and diabetes mellitus, and one, age 62, had angina pectoris and hypertension. One son was reported to have elevated serum TG levels and six other children and eight grandchildren were alive and well.
Examination showed a healthy-appearing woman, 166 cm in height and weighing 67.6 kg. There was no corneal arcus or skin or tendon xanthomata. The fundi were normal. Her pulse was 78 per min and blood pressure 140/80 mmHg. The heart, lungs, and peripheral pulses were normal except for a left carotid systolic bruit, absent dorsalis pedis, and diminished posterial tibial pulses bilaterally. There were no enlarged abdominal organs. The remainder of the examination was normal.
Ultrasound studies showed a 50-60% narrowing ofthe left internal carotid artery and a smaller plaque near the origin of the right carotid artery. Her electrocardiogram was normal. Radiograms showed calcification ofthe aortic arch compatible with atherosclerosis. Ultrasonography of the abdomen revealed a normal pancreas, liver, gall bladder, and bile ducts with no stones.
Routine laboratory tests showed normal values for urinary protein and sugar, for blood glucose, fasting and 2 h after 75 g ofglucose per os, for serum uric acid, electrolytes, glutamic oxaloacetic transaminase activity, creatinine, urea, bilirubin, calcium, phosphate, amylase, tests of thyroid function, albumin, and globulin. Mild normochromic, normocytic anemia was evident. The hemoglobin was 11.8/ml, the red cell count was 4.16 X 106/ml, platelet count was 192 X 103/ml, and white blood cell count 3.9 X 103/ml. The blood smear showed normal red blood cells except for a few microcytes, polychromatic cells, and target cells.'The peripheral blood had a reticulocyte count of 13%, neutrophils 81%, lymphocytes 17%, and eosinophils 2%. The following blood studies were normal: red blood cell osmotic fragility test, serum haptoglobin, prothrombin time, activated partial thromboplastin time, fibrinogen titers, euglobulin lysis, bleeding time, and Factor XIII.
The fasting plasma after standing overnight at 4VC had diffuse lipemia throughout and a chylomicron layer on top. The total cholesterol concentration was 190 mg/dl and TG was 1,325 mg/dl. She was instructed in an American Heart Association phase III diet that allowed 1,200 kcal/d, 20% ofenergy as fat, < 150 mg ofcholesterol and a ratio of polyunsaturated to saturated fatty acids of 1: 1, and she was permitted to take 1 g of clofibrate twice daily. During follow up, every few months for the next two years, the plasma lipid concentrations for cholesterol have ranged from 132 to 360 mg/dl and for TG from 960 to 3,220 mg/dl, and there has been no recurrence of pancreatitis.
Brother 12 .6 g/dl, red cell count 4.38 X 106/ml, white blood count 2.8 X 103/ml, platelet count 58 X 103/ml, the erythrocyte sedimentation rate was 52 mm/h, and the peripheral blood had a reticulocyte count of 6%, neutrophils 75%, lymphocytes 21%, monocytes 2%, eosinophils 1%, and basophils 1%. Red cell agglutination and white blood cells that were not intact were noted in the blood film.
The procedures followed in these studies were in accordance with the ethical standards of the University of Toronto Committee on Human Experimentation.
Plasma lipids and lipoproteins
The plasma lipid and lipoprotein profile was determined afer the Lipid Research Clinic's protocol (17). Blood samples were obtained from subjects-after a 12-16-h fast and collected into tubes containing Na2-EDTA. The plasma was centrifuged using a Beckman 50.3 rotor in a L8-80 ultracentrifuge at 20,000 'rpm for 30 min to isolate the chylomicron fraction. The remaining plasma was centrifuged at 45,000 rpm for 18 h to isolate the VLDL. The cholesterol and TG of the LDL and HDL was determined after precipitation ofthe LDL with heparin and manganese chloride. The total cholesterol and TG ofthese fractions were measured using the Technicon AA-II method, which was standardized with the assistance ofthe Lipid Standardization Laboratory of the Centers for Disease Control (Atlanta, GA).
The plasma lipoproteins were also fractionated by sequential ultracentrifugation as follows: chylomicrons, 20,000 rpm for 30 min; VLDL, 45,000 rpm for 18 h; LDL, isolated from plasma, adjusted to a density of 1.063 g/ml, by centrifugation at 45,000 rpm for 18 h; and HDL, isolated from the remaining plasma after adjusting the density to 1.21 g/ml and centrifugation at 45,000 for 48 h (18). The chylomicrons and VLDL were washed one time by centrifugation under the conditions of isolation. The cholesterol, phospholipid, cholesteryl ester, and TG of each fraction was quantitated by temperature-programmed gas chromatography (19) . The protein content of each fraction was determined using a modification of the Lowry method (20). The stoichiometry of lipid molecules per lipoprotein particle was calculated using the equations of Shen et al. (21) .
Electrophoretic analysis ofthe apolipoproteins of chylomicrons and VLDL
The isolated chylomicrons and VLDL were dialyzed against 0.01% Na2-EDTA, pH 7.4, aliquoted, lyophilized, and delipidated with ethanol/diethyl ether (3:1) (22) . The apolipoproteins were separated by isoelectric focusing using pH 4 to 6 ampholines (LKB, Sweden) as previously described (1 1). Aliquots of 50 ,g were electrophoresed on 3-mm diam gels and separated in a second dimension of sodium dodecyl sulfate-glycerol gel electrophoresis (23) . The gels were either stained with Coomassie Blue G-250 or the proteins were transferred to nitrocellulose filters and immunoblotted with rabbit antihuman apo-CII as previously described (1 1, 24 Pyridyethyl-apoCIIs (PY-4poCIIs) was purified by preparative flatbed isoelectric focusing using Ultradex granulated gel and pH 4 to 6 ampholines as previously described for apoCTIT (12) with the following modifications introduced to minimize oxidation of apolipoproteins during electrophoresis. The gel solution contained 15 mM DTT, and after the gel slurry was poured into the Hoeffer Isobox apparatus, excess liquid was removed by capillary action using paper wicks. The apparatus was also modified to allow a N2 atmosphere to be established over the gel during electrophoresis by making inlet and outlet holes in the plexiglass cover. Finally, light was excluded by covering the electrophoresis chamber with black plastic. The isolated PY-apoCIIs was found to give a single band in analytical isoelectric focusing. Immunoblot showed that it reacted only with antiserum specific for apoCII and not with antiserum to apoCIII or apoAII.
PY-apoCIIs (10-jig aliquot) was hydrolyzed with 6 N HCl at 1 10°C
for 20 h. The amino acid composition was determined by using a Beckman 120C amino acid analyzer and standard elution conditions (27 Each peptide was collected and the amino acid composition determined as described above. The amino acid sequence of selected peptides was determined in an Applied Biosystems 470A sequenator. The phenylthiohydantoin derivatives of the amino acids were identified by reverse-phase HPLC according to the manufacturers' specifications.
Assay ofapoCII activation ofbovine milk LPL The ability of the patient's whole plasma to activate bovine milk LPL was assayed essentially as described by Kashyap et al. (28) . [ '4C]Triolein emulsified with Triton X-100 was used as the substrate and the release of FFA was determined after a 30-min incubation. The assay was linear from 0.1 to 1 ml ofnormal plasma. Activities were expressed as micromoles FFA X 10-3 released per milliliter ofplasma per minute.
Assay ofLPL and hepatic lipase (HL)
LPL and HL were released into the blood by the administration of a bolus of heparin (100 U/kg body wt). The postheparin plasma was collected one-half hour after injection of heparin and the activity of LPL and HL were determined using ['4Cltriolein emulsified with Triton X-100 (29, 30) as a substrate. The total lipolytic activity was assayed in the presence of normal plasma which served as a source of apoCIl. The activity of HL was determined after inhibition of LPL by preincubation with protamine sulfate. LPL activity was taken as the difference between the total lipolytic activity and the HL activity. The linearity ofthe assay was established for each subject. The activities are expressed as micromoles FFA released per milliliter plasma per hour.
Results
Lipoprotein analysis. The proband and her brother both presented with fasting chylomicronemia (Table I) . Their initial total serum cholesterol values were 190 and 87 mg/dl and TG values were 1,325 and 788 mg/dl, respectively. The brother had consistently lower concentrations of chylomicrons, possibly due to prior treatment from his referring physician with diet and lorelco. The plasma LDL and HDL of both subjects were TG rich. The LDL and HDL cholesterol concentrations were significantly below the fifth percentile for subjects of the same age and sex (31) . These results were similar to those that we have observed for homozygotes for apoCIIT (1) .
The average number of molecules per particle of the lipoproteins ofthe proband and her brother are presented in Table  II . The chylomicrons from these subjects had a free cholesterol content that exceeded the amount ofphospholipid. Since it has been estimated that a 1:1 mole ratio of free cholesterol to phospholipid is the maximum physically possible in the surface monolayer, this suggests that a significant percentage of the free cholesterol would be dissolved in the core of the parti- (Table III) . LPL activity of each patient was normal when assayed in the presence of plasma from a control subject with normal apoClI. The activities of HL were significantly below normal values, similar to a previous report on subjects homozygous for apoCIIT (34) .
ApoCII activation ofbovine milk LPL. The plasma from each patient was tested as a source of activator of bovine milk LPL (Table III) . The patient's plasma activated bovine milk LPL to 14% of the normal control value. The activities obtained for the apoCIIs homozygotes were identical to those of patients homozygous for aPOCIIT (3, 12) , consistent with the absence of functional apoCII.
Isoelectric focusing of apochylomicron and apo VLDL. The apolipoproteins of the chylomicrons and the VLDL were investigated by isoelectric focusing. All results shown were obtained using the apolipoproteins of the proband. Identical results were seen for the apolipoproteins of the brother. We noted that the isoelectric focusing pattern was sensitive to oxidation. The pattern in the absence of DTT (Fig. 1, DT-) normally focus. This resolved to an apparently normal pattern when the sample was reduced with DTT ( Fig. 1, DT+) , giving a band with the pI of normal apoCII. However, the ratio of apoCII and apoCIII in the reduced sample was 0.15, as determined by densitometry of the Coomassie Blue-stained gels, which is about one-half the normal ratio of 0.25-0.30 (4) .
The unusual apoprotein bands were positively identified as apoCII by immunoblot with a rabbit antiserum to human apoCII (Fig. 1 B) . At least six different bands could be identified by immunoblot analysis of the nonreduced sample (DT-), with two major bands in the region near normal apo-CII. Two isoforms ofapoCIl were identified by immunoblot of the reduced apolipoproteins (DT+). The major form had a pI indistinguishable from that of normal apoCII. The minor isoform was more acidic than the major isoform. These results suggested that the apoCII of these patients was a mutant that contained a cysteine residue, in contrast to normal apoCII, which does not contain cysteine. To demonstrate the presence of cysteine, the reduced apolipoproteins were carboxyamidomethylated with iodoacetamide, carboxymethylated with iodoacetic acid, which introduces one negative charge per cysteine residue, or pyridylethylated with 4-vinylpyridine, which introduces one positive charge per cysteine residue. The results are shown in Fig. 1 . Treatment with either iodoacetate or 4-vinylpyridine resulted in the disappearance of apoCII from its normal position and, as identified by immunoblot, resulted in a charge shift in apoCII that was consistent with the presence of a single cysteine residue per mole.
The apoE of both patients had the pl of apoE-4, which is known to differ from apoE-3 and apoE-2 by the absence of cysteine (35) . There was no charge shift of the apoE in these experiments (Fig. 1 A) , confirming that these subjects were homozygous for apoE-4.
Two-dimensional electrophoresis of apoVLDL. The mutant apoCII was further characterized by two-dimensional electrophoresis with isoelectric focusing in the first dimension and sodium dodecyl sulfate-glycerol polyacrylamide gel electrophoresis in the second dimension. The patterns of reduced apoVLDL from a subject with normal apoCII and reduced apochylomicrons from the proband with nonfunctional apo-CII are shown in Fig. 2 . Normal apoCII (Fig. 2 1) (36) . The pattern ofthe reduced apolipoproteins of the apoCIIs proband (Fig. 2 2) showed that normal apoCII was absent and that all of the immunologically identifiable apoCII had a molecular weight estimated to be 12,300, with a major isoform with a pI of 4.88 and a minor isoform with a pI of4.74. The presence ofa major and a minor isoform may be analogous to the major and minor isoforms that we observed for normal apoCII and for apoCIIT ( 1) . The pI 4.74 isoform is most likely the result of a posttranslational modification of the pI 4.88 isoform. Two-dimensional electrophoresis of a nonreduced sample is shown in Fig. 3 . The mutant apoCII was difficult to detect by Coomassie Blue stain. The apoCII was positively identified by immunoblot. It was observed to have three different molecular weights that were estimated to be 12,400, 20,800, and 24,600. The 1 2,400-mol-wt form consisted of one major spot and one minor spot that corresponded to the forms seen for the reduced apolipoprotein. The 24,600-mol-wt form had one major spot detectable by Coomassie Blue stain and three spots detectable by immunoblot. The 20,800-mol-wt form also had one major spot detectable by Coomassie Blue stain and two spots detectable by immunoblot. These seven isoforms corresponded well with the isoforms observed by one-dimensional isoelectric focusing (Fig. 1 A, DT-) . The dimerization of the SDS-* 35k 28k w two isoforms of the mutant apoCII would result in three isoforms of 24,600-mol-wt. This corresponds to the higher molecular weight form. The 20,800-mol-wt forms are consistent with apoCII/apoAII dimers. ApoAII was identified by immunoblot with anti-apoAll antiserum (data not shown). We cannot determine from these experiments whether apoCIIs exists in vivo as a monomer or a disulfide bridged dimer. It is possible that the formation of homodimers and heterodimers is an artifact of the isolation procedure.
Thus the mutant nonfunctional apoCII was distinguished from normal apoCII by the presence of cysteine and an apparently higher molecular weight. The absence of normal apoCII in these subjects is consistent with their being homozygous for a mutation in apoCII.
Amino acid composition and sequence analysis ofapoCIIs and its tryptic peptides. The amino acid composition of PYapoCIIs and normal apoCII are compared in Table IV with the amino acid composition derived for normal apoCII from the published amino acid sequence (37) . There were numerous differences, including an increase in proline, glycine, alanine, isoleucine, phenylalanine, and arginine. The lower content of tyrosine in PY-apoCIIs compared with normal apoCII was due to the loss of tyrosine during the acid hydrolysis as a result of the relatively small amounts of PY-apoCIIs analyzed. A similar loss of tyrosine was observed in the amino acid analyses of the isolated peptides (Tables V and VI) .
Tryptic peptides of PY-apoCIIs and apoCII were separated by reverse-phase HPLC (Fig. 4) . Six major peaks were identified in the profile of normal apoCII. Seven major peaks were identified in the profile of PY-apoCIIs. On the basis of retention time and amino acid composition (Table V) P2', P3', P4', and P5' of PY-apoCIIs were determined to be identical, within experimental error, to peaks P1, P2, P3, P4, and P5 of normal apoCIl. These peaks correspond to residues 1 to 48 and 51 to 55 of normal apoCII. The dipeptide, Leu49Arg50, was not detected. The profile of PY-apoCIIs did (37) .
not contain a peak corresponding to P6 of normal apoCII. Two new peaks, identified as P3.1' and P6', were observed. Their amino acid composition (Table VI) did not correspond to any tryptic peptide predicted for normal apoCII. Peak P6' was determined to contain pyridylethyl-cysteine using the relative absorbance at 254 and 226 nm (25) . The unlabeled peak eluting between P2' and P3' of the chromatogram of PY-apoCIus tryptic peptides (Fig. 4) did not yield any amino acids upon analysis and was apparently not an authentic peptide. The peaks eluting later than P6' appear in that part of the chromatogram that typically contains incompletely cleaved products of the tryptic digest of apoproteins. The amino acid sequences determined for the peptides in peaks P3.1' and P6' are shown in Table VII . The first residue of P6' was identified as either Asp or Ser. The next 13 residues were identical with residues 57 to 69 of normal apoCII. However, the sequence differed starting at residue 70 of normal apoCII, where Gln70 was replaced by Pro70. The residue at cycle 17 was tentatively identified as Ser. No amino acid was identified at cycle 19. Gly at cycle 22 was the last residue that could be positively identified.
The sequence of P3.1' did not correspond to any known sequence ofnormal apoCII. No residue was detected at cycle 3. The residues at cycles 5 and 7 could not be unambiguously identified. The Ser at cycle 14 was the last residue that could be detected.
By combining the results of the amino acid composition and sequence analysis of P6', it was possible to conclude that this peptide consisted of 23 amino acids corresponding to residues 56 to 78 of the mutant protein. The presence of pyridylethyl-cysteine in this peptide was established by its ultraviolet absorption characteristics. Since P6' was a peptide produced by trypsin, this implied that the single Arg residue (Table VI) would be the COOH-terminal amino acid. Thus, by elimination, the cysteine could be assigned to position 74. Inspection of the DNA sequence of the apoCII gene (38) (39) (40) indicated that the sequence of P6' and P3.1' could be explained by the insertion of a nucleotide in the codon for Asp69 or Gln70. The subsequent translation reading frame shift predicted the sequence shown in Fig. 5 . The sequence of tryptic peptide P6' was identical to the predicted sequence of residues 56 to 78. Peptide P3.1' corresponded to residues 79 to 96 of the predicted sequence. This peptide was the combination of two of the predicted tryptic peptides and contained one internal arginine residue. The lack of proteolytic cleavage at this residue was consistent with the resistance of Arg-Pro bonds to trypsin. ApoCIIs had a calculated molecular weight of 10,524, in contrast to a calculated molecular weight of 8, 915 for normal apoCII.
Discussion
We have identified a new type of apoCII deficiency on the basis ofthe absence of structurally normal apoCII, the absence of functional apoCII, and the presence of a new, mutant form ofapoCII that we propose to call apoCIIs. This mutant apoCII showed considerable heterogeneity in isoelectric focusing gels when analyzed under nonreducing conditions. The heterogeneity was due to the presence of a cysteine residue that contrasted with the absence of cysteine in normal apoCII. Determination of the primary structure showed that the mutation by -1,900. This is within the accuracy of this method for proteins with molecular weights < 12,000 (41) . mote from our laboratory, will be undertaken in order to reveal whether the incidence of premature vascular disease in this family is associated with the apoE-apoCII gene locus.
